Overview
Linchong Su practices practicing medicine in Enshi, China.
Their clinical expertise encompasses Rheumatoid Arthritis (RA), Arthritis, COVID-19, and Cutaneous Lupus Erythematosus (CLE).
They are actively involved in clinical research, co-authoring 20 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Linchong Y. Su
Is Linchong Y. Su a top-rated expert for Rheumatoid Arthritis (RA)?
MediFind is an objective health platform that identifies experts based on real-world data. Linchong Y. Su is classified as an Experienced expert for Rheumatoid Arthritis (RA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Linchong Y. Su participate in research or clinical trials?
Yes. Linchong Y. Su has published 20 articles and abstracts on conditions like Rheumatoid Arthritis (RA). You can view a list of Linchong Y. Su's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ArthritisSu isExperienced. Learn about Arthritis.
- COVID-19Su isExperienced. Learn about COVID-19.
- Cutaneous Lupus Erythematosus (CLE)
- Rheumatoid Arthritis (RA)
- SclerodermaSu isExperienced. Learn about Scleroderma.
- Systemic Sclerosis (SSc)